Skip to main content

Symptomology

HETEROGENEOUS SYMPTOMS

Alexander disease presents with symptoms and severity that vary significantly depending on age of onset, with more severe symptoms and a worse prognosis in those with early onset.1,4,9,10 The disease may include a constellation of symptoms of motor, cognitive, autonomic, gastrointestinal (GI), and bulbar dysfunction.3,4,10,11 

Black and white photo of a boy with an MRI-like image of a brain superimposed on his head. [90]
Images depicted are not actual patients.

Symptom section

hand

MOTOR SYMPTOMS

May present as delayed acquisition of or regression in motor skills in children and as gait difficulties or weakness, including hemiplegia, in adults2,4,9,10,33

brain

Cognitive symptoms

Are more marked and frequent in people with an earlier age of onset,2,32 although cognitive dysfunction or dementia can occur in people with a later age of onset3,4,16

stomach

GI SYMPTOMS

May include recurrent vomiting and gastroesophageal reflux that cause feeding difficulties and can lead to insufficient weight gain1,10,11,34

throat

Bulbar symptoms

May include dysphagia and dysarthria, as well as palatal myoclonus, which is highly suggestive of Alexander disease in adults (but may be a late feature)1,4

CLINICAL FEATURES

Common presenting clinical features of Alexander disease based on age of onset2-4,32:

The clinical triad of seizures, developmental delay, and macrocephaly is an indicator of Alexander disease in infants and young children, although these symptoms are not uniformly present at clinical onset or in all individuals.33

  • Ataxia
  • Muscle weakness
  • Spastic para- or tetraparesis
  • Bulbar signs
  • Palatal myoclonus
  • Autonomic dysfunction
  • Ocular motor abnormalities
infant and child

The clinical triad of bulbar signs, ataxia, and autonomic dysfunction is suggestive of Alexander disease in juveniles and adults,2-4,16,32 and cognitive or psychiatric features may also be present.35,36

  • Macrocephaly
  • Failure to thrive
  • Seizures
  • Spasticity
  • Hyperreflexia
  • Developmental delay
  • Cognitive dysfunction 
boy and adult

Variation in the severity and progression of symptoms is high,4,9 and symptoms are not reliable predictors of outcomes.33 In some cases, different clinical presentations of Alexander disease may be present within the same family,36 and a family history may show related disorders such as multiple sclerosis or adult-onset neurodegenerative conditions.4 

An ICD-10 CM code for Alexander disease was established in 2023 in the United States.
This code (G31.86) will help to37:
Ensure proper insurance coverage for diagnosis and treatment 

An ICD-10 CM code for Alexander disease was established in 2023 in the United States.

This code (G31.86) will help to37:

Allow for the collection of data on the prevalence and incidence

An ICD-10 CM code for Alexander disease was established in 2023 in the United States.

This code (G31.86) will help to37:

Facilitate the identification and recruitment of patients for research studies

An ICD-10 CM code for Alexander disease was established in 2023 in the United States.

This code (G31.86) will help to37:

Enable a deeper understanding of the natural history of the disease

An ICD-10 CM code for Alexander disease was established in 2023 in the United States.

This code (G31.86) will help to37:

Enhance knowledge sharing among healthcare providers and improve care for patients

test

DISEASE PROGRESSION

Alexander disease progression occurs over several months to decades, leading to fatal outcomes.2,4 In most people with a later age of onset, the disease progresses slowly.4 There is a lack of standardized and validated assessments available to monitor disease progression,38 but assessment tools often used in clinical research can be useful for monitoring motor function, cognition, and other measures at various disease stages. These include:

 

  • 10-meter walk test (10MWT)
    A quantitative assessment of ambulation in adults and children over 2 years of age17
  • 88-item gross motor function measure (GMFM-88)
    Captures qualitative changes in mobility (eg, lying and rolling, sitting, walking) in children38
  • Vineland Adaptive Behavior Scales
    Evaluates adaptive behavior in 4 domains (communication, daily living skills, social skills, and motor skills) from birth to 90 years of age10

Alexander disease predominantly arises from de novo pathogenic variants in glial fibrillary acidic protein (GFAP) that disrupt the structure and function of astrocytes in the central nervous system.1,5

Learn more about burden of disease